Zimbabwe has rejected a substantial US health deal worth 367 million US dollars (£272m) over five years over the United States' request for sensitive data.
The decision became public following a government memo dated December was disclosed, revealing that President Emmerson Mnangagwa felt the arrangement was "lopsided".
An official representative has since clarified that the United States was demanding access to genetic material for research and commercial purposes while refused to guarantee the resulting advantages from future vaccines.
"We are forced to start the difficult and regrettable task of ending our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the US had furnished more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has appealed for more dialogue to reach a deal suitable to all parties so the nation's critical HIV treatment initiative can proceed.
Broader Context
This development follows a similar case in neighbouring Kenya, where a court blocked a similar deal with the US after concerns were filed about the security of citizens' health data.
Since resuming office recently, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.
USAID had managed aid for the US government, but Trump argued its spending was "inefficient" and his government was pursuing government-to-government agreements to boost openness and accountability.
Based on reports, 16 nations in Africa have to date agreed to these new health pacts, constituting more than $18.3bn in committed funds.
Details of the Declined Agreement
This assistance for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this partnership would have delivered significant benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy through American-funded programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".
"The proposal required Zimbabwe to provide its genetic material and health information over an extended period, with no equivalent assurance of benefiting from any scientific breakthroughs – such as new medicines or tests – that might result from that shared data," he stated.
"In essence, our country would provide the basic resources for scientific discovery with no certainty that the final treatments would be accessible to our population if a new disease outbreak arise."
National Interest and International Frameworks
Mangwana further said that the American exit from the global health body and its pursuit of one-on-one health agreements were disrupting frameworks already set up via the international organization.
The spokesperson cited its Pandemic Benefit-Sharing framework created to manage potential global health emergencies.
"This framework is intended to ensure that when a nation provides its information, the benefits – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the resources to develop them."
The government's concerns regarding the US deal "are not meant as opposition to America," he added.
"We welcome further discussions with our US partners on how future collaboration might be arranged in a manner that honours the independence and interests of both nations."
Medical Community Reaction
Medical experts stated it understood the official position, but urged that negotiations need to persist given that much of the country's HIV programmes were funded by foreign aid.
"If specific concerns arise, including those relating to information security or implementation frameworks, these can often be resolved through technical clarification and negotiated safeguards," it said.
The situation highlights the continuing challenges between receiving vital foreign assistance and protecting national sovereignty in an ever more interconnected world.